NIH-funded research R21 grant

Choosing the best way to pick people for lung cancer screening

Official title: Cost-Effectiveness of Lung Cancer Screening Strategies For All Populations

Funded at Wake Forest University Health Sciences · NIH-11193965 · Data updated 2026-11-12

This project compares three ways of deciding who should get low-dose CT scans so more high-risk people are found early while using health care resources wisely.

More Lung Cancer research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionWake Forest University Health Sciences
NIH-funded
Lab location1 site (Winston-Salem, United States)
Project startSeptember 22, 2024
Project endJune 30, 2026
Funding year2025
Award (this year)$201,757
NIH project number5R21MD020158-02
Project IDNIH-11193965 on NIH RePORTER

Who could benefit from this research

Could help

People most relevant are adults with a history of smoking or other lung cancer risk factors—typically middle-aged and older adults who might meet current screening criteria.

Less likely to help

People with very low or no lung cancer risk (for example lifelong non-smokers) or those without access to screening services are unlikely to benefit directly from this work.

What this research studies

If you're someone worried about lung cancer because of age or smoking history, this work looks at who would be invited for low-dose CT screening under three common approaches: USPSTF rules, American Cancer Society rules, and a risk model called PLCOm2012. The team will use real-world data and a cost-effectiveness framework to estimate benefits, harms, and costs across different age and smoking groups. They will look at trade-offs like how many cancers are found, false alarms, and how much screening costs the health system. The goal is to build an easy-to-use decision tool so health leaders can choose the best screening approach for different communities.

Why it matters

Potential benefit: If successful, this could help more people at true risk get screened earlier while reducing unnecessary scans and spending.

How similar studies have gone: Low-dose CT screening has been shown to reduce lung cancer deaths and risk models like PLCOm2012 have promising evidence, but direct comparisons of cost-effectiveness across real-world U.S. populations are still limited.

Where this research is happening

  • Wake Forest University Health Sciences
    Winston-Salem, United States
    Active

Researchers

  • Principal investigator: Lin, Meng-Yun — Wake Forest University Health Sciences
  • Study coordinator: Lin, Meng-Yun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.